Human testing of COVAXIN, an Indian-made Corona vaccine, has started at AIIMS from today. Its first dose is given to a 30-year-old man. The person who has been given the vaccine has not had any adverse effects. The vaccine was given at around 1:30 pm. After 2 hours of surveillance, the person is sent to his home.
Head of the vaccine department of AIIMS, Dr. Sanjay Rai said that today only one person has been tried. He has been sent home, but he will remain under the supervision of doctors for the next seven days. The remaining six people have been called on Saturday.
Rai said, "The first person from Delhi was examined two days ago and all his health parameters were found to be in the normal range. He does not have any other disease. The first dose of 0.5 ml from the injection was given to him around 1.30 pm. No side effects have been seen yet

She is under observation for two hours and will be monitored for the next seven days. ”Some of the participants in the clinical trial will be vaccinated on Saturday after screening reports.
The Indian Council of Medical Research (ICMR) has selected 12 institutes including AIIMS for the first and second phase clinical trials of 'Covexin'. The first phase will test 375 people and maximum of these will be from 100 AIIMS.

According to Rai, in the second phase, a total of around 750 people from all 12 institutions will be involved. In the first phase, the vaccine will be tested on healthy people between 18 and 55 years who do not have any other disease.
According to AIIMS director Dr. Randeep Guleria, in the second phase, this test will be done on 750 people between the ages of 12 and 65 years.